Eczema Trial, Recruiting NCT07022288 Sponsor: ChinaNorm Condition: Eczema
Back to Eczema

Eczema Trial, Recruiting

NCT07022288
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are Chinese, male or female, and between 18 and 65 years old (including those aged exactly 18 or 65)
  • People who are generally in good health, with no other ongoing or treated chronic conditions
  • People who have previously received treatment for atopic dermatitis (eczema), such as prescription creams, ointments, antihistamine tablets, or other topical medications used for the condition
  • People whose atopic dermatitis has been assessed by a dermatologist at the start of the trial as meeting a specific set of diagnostic criteria, being mild in severity (a score of 2 or less on a standard scale called the IGA), and being in a stable phase that no longer needs topical treatment
  • People whose skin shows a measured rate of water loss greater than 15g/m²/h at the start of the trial (this is a standard skin barrier test conducted at the trial site)
  • People who are willing to sign an informed consent form and voluntarily take part in the trial
  • People who are willing to use only the products provided by the trial, keep daily diaries, and attend all scheduled visits throughout the study period

Who may not be able to join:

  • People who are planning to become pregnant, are currently pregnant, are breastfeeding, are within 6 months of giving birth, or are unwilling to use appropriate contraception during the trial
  • People whose atopic dermatitis is currently in an active flare-up phase
  • People who are currently in another clinical trial, or who have taken part in another clinical trial within the past 3 months
  • People who have used moisturising products containing skin microbiome-balancing ingredients within the week before enrolling
  • People who have had physical, chemical, or cosmetic skin procedures or treatments within the 3 months before enrolling
  • People who have serious organ damage, cancer, poorly controlled chronic illness, an active infection, a recent major surgery or injury, or a psychological or mental health condition — or who need medications or treatments for another condition that could affect their eczema
  • People whose eczema worsens significantly after using the trial treatment
  • People who have other skin conditions (such as acne, rosacea, infections, or skin tumours) at the area being studied, or other skin features (such as birthmarks or scars) that could interfere with assessments
  • People who regularly scratch or squeeze their eczema lesions
  • People who have a known allergy to any of the products or ingredients being used in the trial
  • People who are unlikely to attend visits on time or follow the trial requirements
  • People the trial investigators consider unsuitable for any other reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ping Xu, Master, Shanghai China-norm Quality Technical Service Co., Ltd.

Phone: 15623206068

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
ChinaNorm
Registry
ClinicalTrials.gov
Start date
20 April 2025
Est. completion
31 August 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Sebum secretion on the skin surface; TEWL on the skin surface; Skin hydration on the skin surface; The pH value of the skin surface; Standardized facial image acquisition by VISIA; The safety and tolerability judgment by dermatologists based on the assessment of interviewed symptoms and observed signs

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov